Christopher E. Shaw

57.2k total citations · 7 hit papers
242 papers, 19.0k citations indexed

About

Christopher E. Shaw is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, Christopher E. Shaw has authored 242 papers receiving a total of 19.0k indexed citations (citations by other indexed papers that have themselves been cited), including 180 papers in Neurology, 119 papers in Genetics and 81 papers in Molecular Biology. Recurrent topics in Christopher E. Shaw's work include Amyotrophic Lateral Sclerosis Research (171 papers), Neurogenetic and Muscular Disorders Research (117 papers) and Parkinson's Disease Mechanisms and Treatments (51 papers). Christopher E. Shaw is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (171 papers), Neurogenetic and Muscular Disorders Research (117 papers) and Parkinson's Disease Mechanisms and Treatments (51 papers). Christopher E. Shaw collaborates with scholars based in United Kingdom, United States and Slovenia. Christopher E. Shaw's co-authors include Ammar Al‐Chalabi, Christopher C.J. Miller, P. Nigel Leigh, Boris Rogelj, Caroline Vance, Steven Ackerley, P. Nigel Leigh, Agnes L. Nishimura, Tibor Hortobágyi and Siddharthan Chandran and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Christopher E. Shaw

241 papers receiving 18.8k citations

Hit Papers

TDP-43 Mutations in Familial and Sporadic Amyotrophic Lat... 2004 2026 2011 2018 2008 2011 2004 2014 2014 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
    2008 2.0k citations Jemeen Sreedharan, Ian P. Blair et al. Science profile →
  2. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43
    2011 859 citations Boris Rogelj, Agnes L. Nishimura et al. profile →
  3. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study
    2004 586 citations Martin R. Turner, Christopher C.J. Miller et al. profile →
  4. Axonal Transport of TDP-43 mRNA Granules Is Impaired by ALS-Causing Mutations
    2014 497 citations Mónica A. Carrasco, Bilada Bilican et al. profile →
  5. ER–mitochondria associations are regulated by the VAPB–PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43
    2014 497 citations Radu Stoica, Kurt J. De Vos et al. profile →
  6. VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis
    2011 454 citations Kurt J. De Vos, Gábor M. Mórotz et al. Human Molecular Genetics profile →
  7. Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models
    2014 341 citations Sami J. Barmada, Andrea Serio et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher E. Shaw United Kingdom 69 12.3k 8.7k 6.9k 3.0k 2.9k 242 19.0k
Rosa Rademakers United States 68 10.4k 0.8× 5.7k 0.7× 3.6k 0.5× 6.0k 2.0× 2.1k 0.7× 269 16.5k
Aaron D. Gitler United States 58 6.7k 0.5× 9.1k 1.0× 2.4k 0.3× 2.0k 0.7× 3.0k 1.0× 118 14.4k
Yasuto Itoyama Japan 76 7.6k 0.6× 6.5k 0.7× 1.4k 0.2× 2.3k 0.8× 4.1k 1.4× 480 20.6k
Peter Heutink Netherlands 60 6.2k 0.5× 6.5k 0.7× 1.5k 0.2× 3.5k 1.2× 3.6k 1.2× 235 16.3k
Nereo Bresolin Italy 71 2.7k 0.2× 10.6k 1.2× 3.1k 0.4× 2.6k 0.9× 2.8k 1.0× 487 18.1k
Shoji Tsuji Japan 65 6.7k 0.5× 8.8k 1.0× 1.1k 0.2× 3.3k 1.1× 6.7k 2.3× 507 17.1k
Kenneth H. Fischbeck United States 66 4.4k 0.4× 13.1k 1.5× 3.8k 0.6× 1.3k 0.4× 9.4k 3.2× 207 18.9k
Marc Cruts Belgium 55 4.4k 0.4× 5.9k 0.7× 1.5k 0.2× 5.8k 2.0× 1.7k 0.6× 148 13.2k
Giacomo P. Comi Italy 62 2.8k 0.2× 9.0k 1.0× 2.7k 0.4× 1.8k 0.6× 2.4k 0.8× 570 15.6k
Michael Sendtner Germany 75 2.6k 0.2× 10.0k 1.1× 4.0k 0.6× 1.3k 0.4× 8.2k 2.8× 225 20.1k

Countries citing papers authored by Christopher E. Shaw

Since Specialization
Citations

This map shows the geographic impact of Christopher E. Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher E. Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher E. Shaw more than expected).

Fields of papers citing papers by Christopher E. Shaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher E. Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher E. Shaw. The network helps show where Christopher E. Shaw may publish in the future.

Co-authorship network of co-authors of Christopher E. Shaw

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher E. Shaw. A scholar is included among the top collaborators of Christopher E. Shaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher E. Shaw. Christopher E. Shaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shum, Carole, Youn‐Bok Lee, Natalia Arias, et al.. (2024). Mutations in FUS lead to synaptic dysregulation in ALS-iPSC derived neurons. Stem Cell Reports. 19(2). 187–195. 4 indexed citations
2.
Spargo, Thomas P, Sarah Opie-Martin, Ahmad Al Khleifat, et al.. (2023). SOD1-ALS-Browser: a web-utility for investigating the clinical phenotype in SOD1 amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 24(7-8). 736–745. 3 indexed citations
3.
Gotkine, Marc, Martina de Majo, Chun Hao Wong, et al.. (2021). A recessive S174X mutation in Optineurin causes amyotrophic lateral sclerosis through a loss of function via allele-specific nonsense-mediated decay. Neurobiology of Aging. 106. 1–6. 5 indexed citations
4.
Lavrov, Arseniy, Luis Garcia‐Gancedo, Jim Parr, et al.. (2020). The use of biotelemetry to explore disease progression markers in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 21(7-8). 563–573. 17 indexed citations
5.
Hop, Paul J., Ramona A. J. Zwamborn, Eilís Hannon, et al.. (2020). Cross-reactive probes on Illumina DNA methylation arrays: a large study on ALS shows that a cautionary approach is warranted in interpreting epigenome-wide association studies. NAR Genomics and Bioinformatics. 2(4). lqaa105–lqaa105. 15 indexed citations
6.
Zhao, Chen, Amit K. Chouhan, Bhuvaneish T. Selvaraj, et al.. (2019). Mutant C9orf72 human iPSC‐derived astrocytes cause non‐cell autonomous motor neuron pathophysiology. Glia. 68(5). 1046–1064. 83 indexed citations
7.
Herman‐Bausier, Philippe, Christopher E. Shaw, Melissa C. Garcia, et al.. (2019). An Amyloid Core Sequence in the Major Candida albicans Adhesin Als1p Mediates Cell-Cell Adhesion. mBio. 10(5). 22 indexed citations
8.
Garcia‐Gancedo, Luis, Arseniy Lavrov, Jim Parr, et al.. (2019). Objectively Monitoring Amyotrophic Lateral Sclerosis Patient Symptoms During Clinical Trials With Sensors: Observational Study. JMIR mhealth and uhealth. 7(12). e13433–e13433. 41 indexed citations
9.
Mehta, Puja R., Ashley Jones, Sarah Opie-Martin, et al.. (2018). Younger age of onset in familial amyotrophic lateral sclerosis is a result of pathogenic gene variants, rather than ascertainment bias. Journal of Neurology Neurosurgery & Psychiatry. 90(3). 268–271. 29 indexed citations
10.
Smith, Bradley, Caroline Vance, Emma L. Scotter, et al.. (2014). Novel mutations support a role for Profilin 1 in the pathogenesis of ALS. Neurobiology of Aging. 36(3). 1602.e17–1602.e27. 81 indexed citations
11.
Martin, Naomi, Sabine Landau, Anna Janssen, et al.. (2014). Psychological as well as illness factors influence acceptance of non-invasive ventilation (NIV) and gastrostomy in amyotrophic lateral sclerosis (ALS): A prospective population study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 15(5-6). 376–387. 44 indexed citations
12.
Bilican, Bilada, Andrea Serio, Sami J. Barmada, et al.. (2012). Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proceedings of the National Academy of Sciences. 109(15). 5803–5808. 257 indexed citations
13.
Palmisano, Ralf, Peter Heimann, Christopher E. Shaw, et al.. (2011). Endosomal accumulation of APP in wobbler motor neurons reflects impaired vesicle trafficking: Implications for human motor neuron disease. BMC Neuroscience. 12(1). 24–24. 39 indexed citations
14.
Vos, Kurt J. De, Gábor M. Mórotz, Radu Stoica, et al.. (2011). VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis. Human Molecular Genetics. 21(6). 1299–1311. 454 indexed citations breakdown →
15.
Shaw, Christopher E., Craig A. Harper, Michael W. Black, & Allan E. Houston. (2010). Initial Effects of Prescribed Burning and Understory Fertilization on Browse Production in Closed-Canopy Hardwood Stands. Journal of Fish and Wildlife Management. 1(2). 64–72. 16 indexed citations
16.
Sreedharan, Jemeen, Ian P. Blair, Xun Hu, et al.. (2008). TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis. Science. 319(5870). 1668–1672. 2037 indexed citations breakdown →
17.
Berg‐Vos, Renske M. van den, Leonard H. van den Berg, Gerard H. Jansen, et al.. (2001). Hereditary pure lower motor neuron disease with adult onset and rapid progression. Journal of Neurology. 248(4). 290–296. 8 indexed citations
18.
Ackerley, Steven, Andrew J. Grierson, Janet Brownlees, et al.. (2000). Using GFP-tagged neurofilament middle chain to investigate slow transport in cultured cortical neurons. European Journal of Neuroscience. 12. 348–348. 1 indexed citations
19.
Shaw, Christopher E., et al.. (1995). Measurement of immune markers in the serum and cerebrospinal fluid of multiple sclerosis patients during clinical remission. Journal of Neurology. 242(2). 53–58. 26 indexed citations
20.
Halton, D.W., Christopher E. Shaw, Aaron G. Maule, & David Smart. (1994). Regulatory Peptides in Helminth Parasites. Advances in Parasitology. 34. 163–227. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosa Rademakers Breakdown of academic impact, for papers by Aaron D. Gitler Breakdown of academic impact, for papers by Yasuto Itoyama Breakdown of academic impact, for papers by Peter Heutink Breakdown of academic impact, for papers by Nereo Bresolin Breakdown of academic impact, for papers by Shoji Tsuji Breakdown of academic impact, for papers by Kenneth H. Fischbeck Breakdown of academic impact, for papers by Marc Cruts Breakdown of academic impact, for papers by Giacomo P. Comi Breakdown of academic impact, for papers by Michael Sendtner
Rankless by CCL
2026